CV risk factors that drive arterial disease in early life have a major impact on future CV risk. Communication about early lifestyle intervention to the public should be a major focus to reduce CV risk in later years.

Educational information

This educational video is part of a series of 4 videos with the theme: Clinical Updates in Management of Cardiovascular Risk.

Educational objectives are:

• To review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk
• To understand the medical need for intensive risk interventions in patients at high CV risk, including diabetes
• To discuss new concepts in cardiovascular risk management including earlier and more intensive intervention and integrate scientific evidence from key clinical trials into practice
• To explore the role of new risk calculation models for cardiovascular risk estimation and communication

Faculty

Prof. John E Deanfield, MD is Professor of Cardiology, Director, National Centre for Cardiovascular Prevention and Outcomes, University College London, United Kingdom

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Pfizer